Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 125
- Companies
Canada’s biggest cannabis underdog SNDL delivers transformational year, & Australia’s medical cannabis sales could soon outpace Canada
Canada’s biggest cannabis underdog SNDL delivers transformational year Cannabis company and liquor retailer, SNDL Inc., had a record net revenue of $240.4 million in Q4 – 4% higher than in the previous quarter and more than 10x its Q4 2021 sales, reports Fintel.
- Press releases
Leading European Cannabis Company, Cannaray Limited, Announces Partnership between Therismos and Canopy Growth for Exclusive Distribution of Medical Cannabis in the UK & Channel Islands.
Therismos, one of the UK’s largest distributors of unlicensed medicines and subsidiary of leading European cannabis company, Cannaray Limited, today announced an exclusive partnership with Canopy Growth Corporation (“Canopy Growth”), a leading Global Cannabis Company.
- Cultivation
Italian Military Halts Production Of Medical Cannabis Production Piling Pressure On Supply Chain
ITALY’s military, which remains the sole producer of medical cannabis in the country, has halted production at its Florence facility amid a ‘chronic shortage of personnel’.
- Events
Cannabis Europa Takes Place as the Cannabis Industry Gains Exponential Global Momentum
Europe’s leading cannabis conference returns to London as adult-use cannabis markets accelerate toward legalization Changing attitudes towards cannabis, economic forces, and heightened sensitivity of social justice issues are just a few of the factors turning the tide of adult-use legalization in Europe.
- Adult-Use
Canadian cannabis sales slow in February, Delaware 22nd state to legalise recreational cannabis, & Louisiana Senators claim they ‘unknowingly created recreational THC market’
Canadian Cannabis Sales Slow in February Cannabis sales across Canada fell 7.5% from C$395.4m in January this to C$365.7m in February, though they remained up 12.8% year-on-year.
- Adult-Use
Luxembourg Government In Race Against The Clock To Pass Long-Awaited Cannabis Legislation Before Elections
LUXEMBOURG’s government has indicated that a long-running campaign for cannabis legalisation may soon make a significant step forward as plans for its state-controlled sale are expected to be submitted imminently.
- Data & Analysis
Cannabis companies look to ‘4/20’ to light up sales, Canadian medical cannabis patients face ongoing costs issues, & Colorado cannabis sales decline
Cannabis companies look to ‘4/20’ to light up sales Cannabis companies across North America are pulling out all the stops to capitalise on 4/20 and generate bumper sales.
- Medical
UK Holds First Ever Debate On ‘Economic Contribution Of Medical Cannabis’
Yesterday the first-ever parliamentary debate on the UK’s rapidly growing medical cannabis industry took place in Westminster Hall, focusing on the ‘economic contribution of medical cannabis’ in the UK.
- CBD Market
What’s Old is New – BRITISH CANNABIS™ Unveils New Non-Novel CBD Food Supplements Range
New white label CBD food products are back – as the UK’s largest independently owned, producer, and distributor launches a range of CBD products and ingredients that brings innovation back to the sector in a post-novel foods world.
- Adult-Use
Celebrating Cannabis In NYC With a Historic 420 Countdown, Curaleaf Restates Sales Forecasts, & Mississauga Allows Cannabis Retail Stores
Celebrating Cannabis In NYC With a Historic 420 Countdown Royal Queen Seeds and Cannabis Now are hosting what has been described as a ‘trailblazing’ event, replicating the iconic New Years Eve Times Square countdown for 420.
- Markets & Stocks
German Announcement Hits Stocks, Ananda Shares Skyrocket, & Futura Medical Launches Flagship Product In The UK
Last week’s announcement from the German Health Minister Dr Karl Lauterbach has seen the stock in a number of companies with significant operations in Germany take a hit.
- Uncategorized
Deutsche Ankündigung trifft Aktien, Ananda-Aktien schießen in die Höhe & Futura Medical führt Flaggschiffprodukt in Großbritannien ein
Die Ankündigung des deutschen Gesundheitsministers Dr. Karl Lauterbach in der vergangenen Woche hat die Aktien einer Reihe von Unternehmen, die in Deutschland stark vertreten sind, in Mitleidenschaft gezogen.











